Showing 13,241 - 13,260 results of 110,960 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (a decrease)) ))', query time: 1.46s Refine Results
  1. 13241

    Table_2_A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene.xlsx by Wei-qing Wu (14758351)

    Published 2023
    “…The pathological changes included glomerular atrophy, increased monocytes in renal interstitial, and the absence of type IV collagen α5. The expression of Col4a5 was significantly decreased in Del-ATGG mouse model. …”
  2. 13242
  3. 13243

    Expression heatmap showing comparison between PAM50 genes subtypes the AR-positive vs AR-negative tumors. by Melissa Davis (3522224)

    Published 2018
    “…<p><b>Heat Map using</b> PAM50 gene signature compared to AR status. Genes that are enriched in ER and AR-negative subtypes (blue bar) show complete absence of expression in a subset of the AR-positive subtypes that is traditionally categorized as ‘unclassified’ subtypes (blue arrow). …”
  4. 13244
  5. 13245

    Socioeconomic disparities and sexual dimorphism in neurotoxic effects of ambient fine particles on youth IQ: A longitudinal analysis by Pan Wang (198097)

    Published 2017
    “…Increased ambient PM<sub>2.5</sub> levels were associated with decreased IQ scores. …”
  6. 13246
  7. 13247
  8. 13248
  9. 13249
  10. 13250

    N<sup>6</sup>-methyladenosine-dependent primary microRNA-126 processing activated PI3K-AKT-mTOR pathway drove the development of pulmonary fibrosis induced by nanoscale carbon blac... by Bin Han (45760)

    Published 2019
    “…We found that both of m<sup>6</sup>A modifications of pri-miRNA-126 and its binding with DGCR8 were decreased after CB treatment, which resulted in the reduction of mature miRNA-126 accompanied by accumulation of unprocessed pri-miRNA-126. …”
  11. 13251
  12. 13252

    Amastigote susceptibility (IC<sub>50</sub>) of the <i>in vitro</i> resistance selection procedure to PMM-MIL combination therapy. by Sarah Hendrickx (321143)

    Published 2017
    “…Exposure to 5 treatment cycles with either PMM (LEM3323 PMM) or MIL alone (LEM3323 MIL) revealed a clear decrease in drug susceptibility (indicated in bold) [<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005620#pntd.0005620.ref021" target="_blank">21</a>].…”
  13. 13253

    Image_1_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.TIF by Ran Xu (316855)

    Published 2021
    “…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”
  14. 13254

    Table_1_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.XLSX by Ran Xu (316855)

    Published 2021
    “…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”
  15. 13255

    Table_2_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.XLSX by Ran Xu (316855)

    Published 2021
    “…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”
  16. 13256
  17. 13257
  18. 13258
  19. 13259
  20. 13260